1. Home
  2. CSTL vs CNOB Comparison

CSTL vs CNOB Comparison

Compare CSTL & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$32.44

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo ConnectOne Bancorp Inc.

CNOB

ConnectOne Bancorp Inc.

N/A

Current Price

$27.67

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTL
CNOB
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
CSTL
CNOB
Price
$32.44
$27.67
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$46.67
$30.00
AVG Volume (30 Days)
407.5K
285.9K
Earning Date
02-26-2026
01-29-2026
Dividend Yield
N/A
2.59%
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$343,530,000.00
$341,316,000.00
Revenue This Year
$2.88
$38.80
Revenue Next Year
N/A
$7.49
P/E Ratio
N/A
$17.04
Revenue Growth
10.15
36.38
52 Week Low
$14.59
$20.61
52 Week High
$44.28
$29.28

Technical Indicators

Market Signals
Indicator
CSTL
CNOB
Relative Strength Index (RSI) 24.66 58.72
Support Level $38.20 $27.37
Resistance Level $40.88 $28.40
Average True Range (ATR) 1.98 0.91
MACD -1.10 0.00
Stochastic Oscillator 3.79 62.42

Price Performance

Historical Comparison
CSTL
CNOB

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: